In the present study, we have revealed that TANK-binding kinase 1 (TBK1) activity is markedly reduced in the lesions of sporadic ALS patients and ALS model mice, which is associated with MAM disruption. The gene discussed is TBK1; the disease is amyotrophic lateral sclerosis.